AMENDMENT TO PROMISSORY NOTESPromissory Notes • July 13th, 2009 • Cardium Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Amendment to Promissory Notes (this “Amendment”) is made as of this 10th day of July, 2009 by and among Cardium Therapeutics, Inc., a Delaware corporation (the “Company”), and the Holders (as defined below) of the senior subordinated secured promissory notes issued pursuant to the terms of that certain Note and Warrant Purchase Agreement dated February 27, 2009 (“Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Notes.
AMENDMENT TO PROMISSORY NOTESPromissory Note Amendment • July 13th, 2009 • Cardium Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Amendment to Promissory Notes (this “Amendment”) is made as of this 10th day of July, 2009 by and among Cardium Therapeutics, Inc., a Delaware corporation (the “Company”), and the Holders (as defined below) of the senior subordinated secured promissory notes (the “Notes”) issued pursuant to the terms of that certain Note and Warrant Purchase Agreement dated June 11, 2009. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Notes.
